BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Ignyta Stock Booms on Promising Mid-Stage Lung Cancer Data

  The good news led Ignyta’s stock to jump about five percent before settling down.

  October 17, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Takeda Leaps Into NASH With $470M-Plus Deal With HemoShear Therapeutics

  Takeda is jumping into the $40B market for NASH and other diseases of the liver with a $470M+ investment into HemoShear Therapeutics.

  October 17, 2017

   · 

  2 min read

   · 

  Alex Keown
• Job Trends

  Drug R&D Boom Lead Massachusetts Biotech Jobs to Hit an All-Time High

  And industry trade group MassBio has the jobs numbers and pipeline data to prove it.

  October 17, 2017

   · 

  1 min read
• Drug Development

  OncBioMune Preparing to Initiate Trials of Novel Therapeutic Ovarian Cancer Vaccine

  OncBioMune has begun the process to initiate clinical studies of OvcaVax for ovarian cancer.

  October 17, 2017

   · 

  4 min read
• 

  Biotech Bay

  Forty Seven Bags $75M, Bringing in a Total of $150M in Venture Capital

  The round was led by new investors as well as existing investors.

  October 17, 2017

   · 

  2 min read

   · 

  Mark Terry
• Policy

  Transmed7 Announces 510(K) Submission to the FDA for Its Speedbird Soft Tissue Biopsy Device Platform

  The company has submitted a premarket notification for its innovative SpeedBird soft tissue biopsy device platform with FDA.

  October 17, 2017

   · 

  3 min read
• Biotech Bay

  Precision Medicine Meets Single-Cell DNA Analysis With Mission Bio

  Mission Bio, Inc., a pioneer in single-cell DNA analysis, today announced it has secured $10 million in Series A funding. Silicon Valley venture capital firm Mayfield Fund led the round.

  October 17, 2017

   · 

  6 min read
• Drug Development

  InMed Updates Pain Program

  InMed announced today additional pre-clinical results in the development of INM-405 for the treatment of pain.

  October 17, 2017

   · 

  5 min read
• Business

  Cerevance Licenses Human Brain Tissue Profiling Technology from The Rockefeller University

  Cerevance today announced that it has signed an agreement with The Rockefeller University to license a novel technology for profiling specific cell populations in human brain tissue.

  October 17, 2017

   · 

  1 min read
• 

  Genetown

  Giving Back: Vertex Commits $500M, Creates New Charitable Foundation

  The money will be to provide patient and caregiver support, funding education and investing in the community.

  October 17, 2017

   · 

  3 min read